Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infection.

Autor: Petro CD; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Hooper AT; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Peace A; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Mohammadi K; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Eagan W; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Elbashir SM; Moderna Inc., Cambridge, MA 02139, USA., DiPiazza A; Moderna Inc., Cambridge, MA 02139, USA., Makrinos D; Moderna Inc., Cambridge, MA 02139, USA., Pascal K; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Bandawane P; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Durand M; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Basu R; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Coppi A; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Wang B; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Golubov J; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Asrat S; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Ganguly S; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Koehler-Stec EM; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Wipperman MF; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Ehrlich G; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Gonzalez Ortiz AM; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Isa F; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Lewis MG; Bioqual, Rockville, MD 20850, USA., Andersen H; Bioqual, Rockville, MD 20850, USA., Musser BJ; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Torres M; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Lee WY; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Edwards D; Moderna Inc., Cambridge, MA 02139, USA., Skokos D; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Orengo J; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Sleeman M; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Norton T; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., O'Brien M; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Forleo-Neto E; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Herman GA; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Hamilton JD; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Murphy AJ; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Kyratsous CA; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Baum A; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA.

Publikováno v: Science translational medicine [Sci Transl Med] 2024 Nov 06; Vol. 16 (772), pp. eadn0396. Date of Electronic Publication: 2024 Nov 06.

Higher labor intensity in US automotive assembly plants after transitioning to electric vehicles.

Autor: Weng A; Department of Mechanical Engineering, University of Michigan - Ann Arbor, 1231 Beal Ave, Ann Arbor, MI, US. asweng@umich.edu., Ahmed OY; Department of Mechanical Engineering, University of Michigan - Ann Arbor, 1231 Beal Ave, Ann Arbor, MI, US., Ehrlich G; Department of Economics, University of Michigan - Ann Arbor, 611 Tappan Ave, Ann Arbor, MI, US., Stefanopoulou A; Department of Mechanical Engineering, University of Michigan - Ann Arbor, 1231 Beal Ave, Ann Arbor, MI, US.

Publikováno v: Nature communications [Nat Commun] 2024 Sep 16; Vol. 15 (1), pp. 8088. Date of Electronic Publication: 2024 Sep 16.

Ein erhöhter Fibrinogen-Plasma-Spiegel ist ein negativer prognostischer Faktor beim Urothelkarzinom des oberen Harntraktes

Autor: Ehrlich, G., Pichler, Martin, Hutterer, G., Pummer, K., Zigeuner, R., Dalpiaz, O.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3341::e7ab34e767f6b111e9d849aac7ad48e1
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/105453

A Lithium Ion Cell for the EMU Battery

Autor: Ehrlich, G. M., Gitzendanner, R., Puglia, F., Marsh, C., Bragg, B. J.

Publikováno v: SAE Transactions, 1999 Jan 01. 108, 84-86.

Externí odkaz: https://www.jstor.org/stable/44729387

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.